Sartorius Stedim Biotech agrees to acquire Polyplus for 2.4 billion euros
PARIS, FRANCE: Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has signed an agreement to acquire Polyplus for approximately 2.4 billion euros from private investors, including ARCHIMED and WP GG Holdings IV B.V., an affiliate of Warburg…